Mark Christanson
Founder bei NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Vermögen: 387 737 $ am 31.03.2024
Profil
Mark Christanson is the founder of NeuroOne Medical Technologies Corp., which was founded in 2009.
He held the title of Director-Business Development at the company.
He is currently working at Neuroone, Inc. as the Vice President-Business Development & Marketing since 2016.
Mr. Christanson has previously worked at Robert Half, Inc. as the Head-Business Development from 2009 to 2012, at Cortec Corp.
as the Manager-North American Sales from 2013 to 2016, and at PMT Corp.
(United States) as the Manager-Regional Sales from 2009 to 2012.
He completed his undergraduate degree at Augsburg College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2024 | 323 114 ( 1,25% ) | 387 737 $ | 31.03.2024 |
Aktive Positionen von Mark Christanson
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Founder | 20.08.2009 |
Neuroone, Inc.
 Neuroone, Inc. Hospital/Nursing ManagementHealth Services Neuroone, Inc. operates neurological care centers to treat disorders of the brain and spinal cord. It is a technology platform adds significant value both for payors and patients specifically in the way the company manage treatments for epilepsy, Parkinson’s disease and other neurological disorders. The company was founded in 2016 and is headquartered in Minnetonka, MN. | Sales & Marketing | 01.12.2016 |
Ehemalige bekannte Positionen von Mark Christanson
| Unternehmen | Position | Ende |
|---|---|---|
Cortec Corp.
 Cortec Corp. Chemicals: Major DiversifiedProcess Industries Cortec Corp. engages in the manufacture and supply of corrosion protection inhibitors. It provides corrosion-control products for commercial and consumer applications. It operates through the vapor phase corrosion inhibitor and migrating corrosion inhibitor product lines. The company was founded by Boris Miksic in 1977 and is headquartered in Saint Paul, MN. | Sales & Marketing | 01.12.2016 |
PMT Corp. (United States)
 PMT Corp. (United States) Medical SpecialtiesHealth Technology PMT Corp. is a private company based in Chanhassen, MN. The company develops medical devices and instruments. | Sales & Marketing | 01.02.2012 |
| ROBERT HALF INTERNATIONAL, INC | Corporate Officer/Principal | 01.02.2012 |
Ausbildung von Mark Christanson
| Augsburg College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROBERT HALF INTERNATIONAL, INC | Commercial Services |
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cortec Corp.
Cortec Corp. Chemicals: Major DiversifiedProcess Industries Cortec Corp. engages in the manufacture and supply of corrosion protection inhibitors. It provides corrosion-control products for commercial and consumer applications. It operates through the vapor phase corrosion inhibitor and migrating corrosion inhibitor product lines. The company was founded by Boris Miksic in 1977 and is headquartered in Saint Paul, MN. | Process Industries |
Neuroone, Inc.
Neuroone, Inc. Hospital/Nursing ManagementHealth Services Neuroone, Inc. operates neurological care centers to treat disorders of the brain and spinal cord. It is a technology platform adds significant value both for payors and patients specifically in the way the company manage treatments for epilepsy, Parkinson’s disease and other neurological disorders. The company was founded in 2016 and is headquartered in Minnetonka, MN. | Health Services |
PMT Corp. (United States)
PMT Corp. (United States) Medical SpecialtiesHealth Technology PMT Corp. is a private company based in Chanhassen, MN. The company develops medical devices and instruments. | Health Technology |
